Metastasis & Drug Resistance

The management of cancer involves procedures, which include surgery, radiotherapy and chemotherapy. Development of chemoresistance is a persistent problem during the treatment of local and disseminated disease. A plethora of cytotoxic drugs that selectively, but not exclusively, target actively proliferating cells include such diverse groups as DNA alkylating agents, antimetabolites, intercalating agents and mitotic inhibitors. Resistance constitutes a lack of response to drug-induced tumour growth inhibition; it may be inherent in a subpopulation of heterogeneous cancer cells or be acquired as a cellular response to drug exposure.

 

 

 

  • Homeostasis
  • Cancer drug resistance 
  • absorption, distribution, metabolism and elimination (ADME)
  • Drug-resistant tumour subpopulation.
  • Multiple drug Resistance

Related Conference of Metastasis & Drug Resistance

March 24-25, 2020

International Meeting on Reproductive Medicine and Womens Health

Amsterdam | Netherlands
June 11-12, 2020

7th Asia Pacific Gynecology and Obstetrics Congress

Singapore City, Singapore
July 17-18, 2020

2nd World Conference on Breast and Cervical Cancer

Helsinki, Finland
September 09-10, 2020

International Conference on Gynecology

Valencia, Spain
October 19-20, 2020

World Congress on Gynecology and Obstetrics

Tokyo, Japan

Metastasis & Drug Resistance Conference Speakers

Recommended Sessions

Related Journals

Are you interested in